Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.
Helaina has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Helaina's investors include Primary Venture Partners, Spark Capital, Plum Alley, Avidity Partners, Cosmic Venture Partners.
Helaina is headquartered in New York, United States.
Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.
Helaina is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helaina — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/helaina. Accessed July 19, 2026.
VCBacked. (2024). Helaina — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/helaina
{{cite web |title=Helaina — Funding & Investors |url=https://www.vcbacked.co/company/helaina |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated